These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. Wang Y, Kuo S, Shu M, Yu J, Huang S, Dai A, Two A, Gallo RL, Huang CM. Appl Microbiol Biotechnol; 2014 Jan; 98(1):411-24. PubMed ID: 24265031 [Abstract] [Full Text] [Related]
4. A systematic review of N-acetylcysteine for treatment of acne vulgaris and acne-related associations and consequences: Focus on clinical studies. Mardani N, Mozafarpoor S, Goodarzi A, Nikkhah F. Dermatol Ther; 2021 May; 34(3):e14915. PubMed ID: 33629414 [Abstract] [Full Text] [Related]
5. A Precision Microbiome Approach Using Sucrose for Selective Augmentation of Staphylococcus epidermidis Fermentation against Propionibacterium acnes. Wang Y, Kao MS, Yu J, Huang S, Marito S, Gallo RL, Huang CM. Int J Mol Sci; 2016 Nov 09; 17(11):. PubMed ID: 27834859 [Abstract] [Full Text] [Related]
6. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris. Han R, Blencke HM, Cheng H, Li C. Peptides; 2018 Jan 09; 99():36-43. PubMed ID: 29108811 [Abstract] [Full Text] [Related]
7. The increasing importance of the gut microbiome in acne vulgaris. Siddiqui R, Makhlouf Z, Khan NA. Folia Microbiol (Praha); 2022 Dec 09; 67(6):825-835. PubMed ID: 35711021 [Abstract] [Full Text] [Related]
14. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions. Nishijima S, Kurokawa I, Katoh N, Watanabe K. J Dermatol; 2000 May 19; 27(5):318-23. PubMed ID: 10875198 [Abstract] [Full Text] [Related]
15. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes. Poomanee W, Chaiyana W, Mueller M, Viernstein H, Khunkitti W, Leelapornpisid P. Anaerobe; 2018 Aug 19; 52():64-74. PubMed ID: 29906773 [Abstract] [Full Text] [Related]
16. Propionibacterium acnes and antimicrobial resistance in acne. Dessinioti C, Katsambas A. Clin Dermatol; 2017 Aug 19; 35(2):163-167. PubMed ID: 28274353 [Abstract] [Full Text] [Related]
17. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. O'Neill AM, Gallo RL. Microbiome; 2018 Oct 02; 6(1):177. PubMed ID: 30285861 [Abstract] [Full Text] [Related]
18. Acne, Microbiome, and Probiotics: The Gut-Skin Axis. Sánchez-Pellicer P, Navarro-Moratalla L, Núñez-Delegido E, Ruzafa-Costas B, Agüera-Santos J, Navarro-López V. Microorganisms; 2022 Jun 27; 10(7):. PubMed ID: 35889022 [Abstract] [Full Text] [Related]
19. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. Patel M, Bowe WP, Heughebaert C, Shalita AR. J Drugs Dermatol; 2010 Jun 27; 9(6):655-64. PubMed ID: 20645527 [Abstract] [Full Text] [Related]
20. Acne microbiome: From phyla to phylotypes. Dreno B, Dekio I, Baldwin H, Demessant AL, Dagnelie MA, Khammari A, Corvec S. J Eur Acad Dermatol Venereol; 2024 Apr 27; 38(4):657-664. PubMed ID: 37777343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]